Approval of Pfizer Pills for High-Risk COVID-19 Patients

Pfizer's medication pills have received emergency use authorization in the United States, providing a more convenient treatment option for at-risk patients at a critical stage of the pandemic. The drug, named "Paxlovid," is the first at-home treatment for COVID-19 to be approved by the U.S. Food and Drug Administration. The medication is expected to become a powerful weapon against the virus as production begins, allowing at-risk individuals to avoid the need for hospitalization due to serious complications. Bloomberg News quoted Patricia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, stating on Wednesday in a press release, "This authorization provides a new tool to combat COVID-19 at a critical time in the pandemic with the emergence of new variant strains."